Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008
Status:
Completed
Trial end date:
2020-10-26
Target enrollment:
Participant gender:
Summary
In the pilot Part A of this study, multiple doses of CA-008 will be evaluated for safety,
tolerability and PK. Doses will then be selected for the expanded, main part of the study
where CA-008 will be compared to placebo. Patients will have serial assessments of safety,
PK, and drug effect.